Description
TVHS PHARMACEUTICAL SERVICES IDIQ -DE-OBLIGATION EXCESS FUNDS AND CLOSEOUT
Base award description: TVHS PHARMACEUTICAL SERVICES IDIQ - 4 MONTH EXTENSION 52.217-8
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-06-01+$20,000= $20,000
- Mod P000012022-09-28+$0= $20,000
- Mod P000022023-01-12-$9,305= $10,695
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-06-01 | +$20,000 | $20,000 | TVHS PHARMACEUTICAL SERVICES IDIQ - 4 MONTH EXTENSION 52.217-8 |
| Mod P00001· EXERCISE AN OPTION | 2022-09-28 | +$0 | $20,000 | TVHS PHARMACEUTICAL SERVICES IDIQ - 4 MONTH EXTENSION 52.217-8 |
| Mod P00002· FUNDING ONLY ACTION | 2023-01-12 | −$9,305 | $10,695 | TVHS PHARMACEUTICAL SERVICES IDIQ -DE-OBLIGATION EXCESS FUNDS AND CLOSEOUT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RQ68XNJUBBV5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24825N0335 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · Q517 · PHARMACY SERVICES | $850,000 | FY2025 |
| 36C26324P0478 | NETWORK CONTRACT OFFICE 23 (36C263) · Q517 · PHARMACY SERVICES | $11,100 | FY2024 |
| 36C24824N0321 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · Q517 · PHARMACY SERVICES | $623,272 | FY2024 |
| 36C25223F0276 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · Q702 · TECHNICAL MEDICAL SUPPORT | $735,156 | FY2023 |
| 36C24823N0315 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · Q517 · MEDICAL- PHARMACOLOGY | $539,591 | FY2023 |
| 36C25223F0078 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $230,962 | FY2023 |
Other recipients under R799 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24926F0229 | REDHAWK IT SOLUTIONS, LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $129,501 | FY2026 |
| 36C24924P1152 | MINBURN TECHNOLOGY GROUP, LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $63,111 | FY2024 |
| 36C24923P0941A | VITAL TALK | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $2,295 | FY2023 |
| 36C24922F0354 | TELECOMMUNICATION SOLUTIONS GROUP INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $117,490 | FY2022 |
| 36C24922F0067 | FOUR POINTS TECHNOLOGY, L.L.C. | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $65,525 | FY2022 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24922N0318_3600_VA24917D0150_3600 · retrieved 2026-09-26.